Consistently, we confirmed that WIP1 suppression together with PARP inhibition induced synthetic lethality in HCC via enhancing DNA damage, and combination of WIP1 and PARP inhibition suppressed HCC cell proliferation significantly both in vitro and in vivo (Figs. 5, 6, 7). Here, PARP1 is linked to hepatocellular carcinoma.